TLR7 and systemic lupus erythematosus: In addition, Salvi et al. (31) reported that microRNA delivered by SLE exosomes activates human plasmacytoid DCs to secrete IFN-α through TLR7, indicating that microRNA can be used as a potential target for the treatment of SLE.